01-12-2006 | Original Article
Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
Published in: Medical Oncology | Issue 4/2006
Login to get access01-12-2006 | Original Article
Published in: Medical Oncology | Issue 4/2006
Login to get access